MWAM
ABBV icon

Manhattan West Asset Management’s AbbVie ABBV Stock Holding History

Manhattan West Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Sell
2,708
-255
-9% -$54.9K 0.11% 102
2026
Q1 		$645K Buy
2,963
+103
+4% +$22.8K 0.13% 99
2025
Q4 		$654K Sell
2,860
-69
-2% -$15.7K 0.13% 95
2025
Q3 		$678K Sell
2,929
-228
-7% -$46.4K 0.14% 96
2025
Q2 		$586K Buy
3,157
+236
+8% +$43.9K 0.14% 95
2025
Q1 		$612K Buy
2,921
+481
+20% +$93.5K 0.16% 88
2024
Q4 		$434K Sell
2,440
-208
-8% -$38.2K 0.12% 100
2024
Q3 		$523K Buy
2,648
+30
+1% +$5.6K 0.14% 101
2024
Q2 		$449K Sell
2,618
-26
-1% -$4.31K 0.12% 104
2024
Q1 		$481K Buy
2,644
+26
+1% +$4.48K 0.12% 103
2023
Q4 		$406K Sell
2,618
-416
-14% -$60.6K 0.11% 104
2023
Q3 		$439K Buy
3,034
+333
+12% +$48.9K 0.14% 104
2023
Q2 		$364K Buy
2,701
+465
+21% +$68.2K 0.14% 100
2023
Q1 		$356K Buy
+2,236
New +$342K 0.16% 97

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manhattan West Asset Management's ABBV Position: Q2 2026 in Review

Manhattan West Asset Management reduced its AbbVie (ABBV) stake by 8.6% in Q2 2026, selling an estimated $54.9K and leaving 2,708 shares worth $682K. The position accounts for 0.11% of the portfolio, ranked #102.

Manhattan West Asset Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Manhattan West Asset Management held 2,708 shares of AbbVie worth $682K as of Q2 2026.
  • Manhattan West Asset Management sold 255 AbbVie shares in Q2 2026, an estimated $54.9K.
  • AbbVie made up 0.11% of Manhattan West Asset Management's portfolio in Q2 2026, its #102 holding.
  • Manhattan West Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Manhattan West Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.